Phreesia, which provides a patient-intake software platform for healthcare providers, filed on Friday with the SEC to raise up to $125 million in an initial public offering.
The New York, NY-based company was founded in 2005 and booked $104 million in sales for the 12 months ended April 30, 2019. It plans to list on the NYSE under the symbol PHR. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray are the joint bookrunners on the deal. No pricing terms were disclosed.
The article Healthcare software provider Phreesia files for a $125 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
